Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the ...

Merck's Gardasil vaccine sales over the quarters Still, sales of Keytruda, the world's top-selling prescription medicine, more than offset that shortfall. The company sold over $7.8 billion worth ...

All patients in the trial will have the opportunity to resume or begin treatment with Winrevair, the company said.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating ...

India], February 12: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks 'International Day of Girls and ...

The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...